<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20110228005931N13</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-13</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effectiveness of web-based unified transdiagnostic treatment with specific diagnosis</public_title>
      <acronym></acronym>
      <scientific_title>Comparison effectiveness of web-based unified transdiagnostic treatment versus diagnosis-specific internet psychotherapies for improvement of psychological distress in women with threatened abortion</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>116</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68199</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: One hundred sixteen eligible participants will allocate randomly two groups (58 individuals) by permuted block randomization method. Group A (unified transdiagnostic treatment) and group B (diagnosis-specific) including three subgroups of depression, anxiety, and obsession will be received. The size of each block will be considered 12 using the statistical program on (seadenvelope.com). In each block, 6 times group A and 6 times group B (2 repetitions of each disorder) will be considered and produce a total of 116 sequences. In order to comply with the concealment sequence, the random list is given to a hospital staff member outside the research team who sends the codes to the principal investigator.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Depression Disorders. Condition 2: Anxiety Disorders. Condition 3: Obsession Compulsive Disorders.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Participants will receive web-based unified transdiagnostic treatment with a duration of  8 weeks, each session 45 minutes. The Unified protocol for transdiagnostic treatment of the emotional disorder(UP) is an emotion-focused cognitive-behavioral intervention that consists of five modules or "core" components based on elements of cognitive behavioral therapy (CBT) with proven effectiveness that address negative emotions and reactivity. It targets the negative aspects of emotions, which include learning to observe emotional experience; cognitive evaluation in creating and maintaining emotional responses, identifying behaviors affected by emotion, awareness of internal and external triggers of emotion, and learning how to prepare a hierarchy of fear and avoidance. Intervention 2: Intervention group 2: Participants will receive web-based diagnosis-specific internet psychotherapies including Internet-based cognitive behavior therapy for three disorders (depression, anxiety, and obsession-compulsion disorders) with a duration of  8 weeks, each session of 45 minutes. Specific strategies used in the protocols include the specific strategies used in the protocols included specific treatment of obsessions (types of obsessions, change of mind, confrontation and response prevention, hierarchy of anxiety, and prevention of relapse), depression: (identification and cognitive re-evaluation, negative automatic thoughts and basic beliefs, exercises to test negative beliefs, identifying schemas and changing them) and anxiety (identification and cognitive re-evaluation, cognitive errors, effective and ineffective coping strategies, behavior change, relaxation sessions).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The data file of the participants will be shared if allowed by the ethics committee of the university.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahbobeh Faramarzi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, Ganjafroz Avenue, Babol, Mazandaran, Iran</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>47745-47176</zip>
        <telephone>+98 11 3219 9595</telephone>
        <email>Mahbob330@yahoo.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farzan kheirkhah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, Ganjafroz Avenue, Babol, Mazandaran, Iran</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>47745-47176</zip>
        <telephone>+98 11 3219 9592</telephone>
        <email>drfarzankh@yahoo.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Education above elementary
Vaginal bleeding related to pregnancy between 5 and 12 weeks
Taking progesterone  due to the threat of abortion
Internet access
Having diagnostic criteria for disorders, including depression (MDD, depression NOS), anxiety disorders (Panic disorder, Generalized anxiety disorder, Agoraphobia, Specific phobia, Social phobia, and anxiety NOS) and Obsessive-compulsive disorders based on the DSM-5 Clinical Structured Interview</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Patients with vaginal bleeding for reasons other than threatened abortion
Patients who became pregnant through assisted reproductive  technology
Patients diagnosed as missed abortion or inevitable miscarriage and ectopic pregnancy on admission
Patients without baseline ultrasound
Severe psychiatric disorders and suicidal ideation
Receiving other psychotherapy at the same time as this study
Lack of informed consent</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Participants will receive web-based unified transdiagnostic treatment with a duration of  8 weeks, each session 45 minutes. The Unified protocol for transdiagnostic treatment of the emotional disorder(UP) is an emotion-focused cognitive-behavioral intervention that consists of five modules or "core" components based on elements of cognitive behavioral therapy (CBT) with proven effectiveness that address negative emotions and reactivity. It targets the negative aspects of emotions, which include learning to observe emotional experience; cognitive evaluation in creating and maintaining emotional responses, identifying behaviors affected by emotion, awareness of internal and external triggers of emotion, and learning how to prepare a hierarchy of fear and avoidance.</i_keyword>
      <i_keyword>Intervention group 2: Participants will receive web-based diagnosis-specific internet psychotherapies including Internet-based cognitive behavior therapy for three disorders (depression, anxiety, and obsession-compulsion disorders) with a duration of  8 weeks, each session of 45 minutes. Specific strategies used in the protocols include the specific strategies used in the protocols included specific treatment of obsessions (types of obsessions, change of mind, confrontation and response prevention, hierarchy of anxiety, and prevention of relapse), depression: (identification and cognitive re-evaluation, negative automatic thoughts and basic beliefs, exercises to test negative beliefs, identifying schemas and changing them) and anxiety (identification and cognitive re-evaluation, cognitive errors, effective and ineffective coping strategies, behavior change, relaxation sessions).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression. Timepoint: Before intervention, after intervention (8 weeks after beginning), fallow-up of 3 month after end of intervention. Method of measurement: Edinburgh Postnatal Depression Inventor.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anxiety. Timepoint: Before the intervention, after intervention (8 weeks after beginning), fallow-up of 3 months after the end of the intervention. Method of measurement: Brief Symptoms Inventory (BSI-18).</sec_outcome>
      <sec_outcome>Obsession- compulsion. Timepoint: Before the intervention, after intervention (8 weeks after beginning), follow-up of 3 months after the end of the intervention. Method of measurement: Yale-Brown Obsessive-Compulsive Scale (Y-BOCS).</sec_outcome>
      <sec_outcome>Emotion regulation. Timepoint: Before intervention, after intervention (8 weeks after beginning), fallow-up of 3 month after end of intervention. Method of measurement: Cognitive emotion regulation questionnaire (CERQ).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-01-09</approval_date>
        <contact_name>Ethic Committee of Babol University of Medical Sciences</contact_name>
        <contact_address>Babol University of Medical Sciences, Ganjafroz Avenue, Babol, Mazandaran, Babol, Iran. Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
